Taxotere Treatment for Metastatic Breast Cancer
Metastatic breast cancer is cancer that began in the breast tissue but has spread to distant organs in the body. The most common places for breast cancer to spread to are the brain, bones, lung and liver. Taxotere (docetaxel) is a treatment option for metastatic breast cancer.
-
Usage
-
Taxotere is given as a chemotherapy treatment for locally advanced or metastatic breast cancer when other chemotherapy regimens have not been effective.
Administration
-
Taxotere is given intravenously and usually takes an hour to be administered. It is usually given every three weeks. Sometimes Decadron (dexamethasone) is prescribed as well, to alleviate side effects.
-
Effectiveness
-
A study published in the Annals of Oncology found that Taxotere was more effective at extending survival time than another commonly used drug for metastatic breast cancer.
Side Effects
-
Side effects of Taxotere may include a low white blood cell count (which can increase a patient's susceptibility to infections), fluid retention, nausea and vomiting, hair loss, fatigue, muscle pain, rashes and diarrhea.
Warning
-
Do not take Taxotere if you are pregnant, if you have a low white blood cell count, abnormal liver function, or if you know you are allergic to the drug or ingredients in the drug.
-